• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

ASO Author Reflections: Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma.

作者信息

Tamburrino Domenico, Guarneri Giovanni, Capurso Gabriele, Falconi Massimo

机构信息

Pancreatic Surgery Unit, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute, Milan, Italy.

Pancreato-Biliary Endoscopy and Endosonography Division, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute IRCCS, Vita-Salute San Raffaele University, Milan, Italy.

出版信息

Ann Surg Oncol. 2021 Apr;28(4):2323-2324. doi: 10.1245/s10434-020-09139-5. Epub 2020 Sep 14.

DOI:10.1245/s10434-020-09139-5
PMID:32929602
Abstract
摘要

相似文献

1
ASO Author Reflections: Chemopreventive Agents After Pancreatic Resection for Ductal Adenocarcinoma.ASO作者反思：导管腺癌胰腺切除术后的化学预防剂
Ann Surg Oncol. 2021 Apr;28(4):2323-2324. doi: 10.1245/s10434-020-09139-5. Epub 2020 Sep 14.
2
ASO Author Reflections: Resection Margins in Distal Pancreatectomy for Ductal Adenocarcinoma-Does Surgery Tell the Whole Story?ASO作者反思：导管腺癌远端胰腺切除术中的切缘——手术能说明全部情况吗？
Ann Surg Oncol. 2022 Jan;29(1):376-377. doi: 10.1245/s10434-021-10515-y. Epub 2021 Jul 24.
3
ASO Author Reflections: Exploring the Oncologic Impact of Pancreatic Fistula after Distal Pancreatectomy for Ductal Adenocarcinoma.美国外科医师学会作者反思：探讨导管腺癌远端胰腺切除术后胰瘘的肿瘤学影响。
Ann Surg Oncol. 2021 Jun;28(6):3184-3185. doi: 10.1245/s10434-020-09314-8. Epub 2020 Nov 21.
4
ASO Author Reflections: Lymphadenectomy in Distal Pancreatectomy for Ductal Adenocarcinoma: How to Do Better?ASO作者反思：导管腺癌远端胰腺切除术中的淋巴结清扫术：如何做得更好？
Ann Surg Oncol. 2022 Mar;29(3):1540-1541. doi: 10.1245/s10434-021-10814-4. Epub 2021 Sep 29.
5
ASO Author Reflections: Do Distinct Patterns of Recurrence Impact the Prognosis of Patients With Resected Pancreatic Ductal Adenocarcinoma?ASO作者反思：复发的不同模式会影响接受手术切除的胰腺导管腺癌患者的预后吗？
Ann Surg Oncol. 2018 Dec;25(Suppl 3):806-807. doi: 10.1245/s10434-018-6820-z. Epub 2018 Oct 8.
6
ASO Author Reflections: Surgical Predictors for Survival in Patients Undergoing Distal Pancreatectomy for Pancreatic Ductal Adenocarcinoma.ASO作者反思：胰腺导管腺癌患者行胰体尾切除术生存的手术预测因素
Ann Surg Oncol. 2020 Dec;27(Suppl 3):854-855. doi: 10.1245/s10434-020-08911-x. Epub 2020 Jul 22.
7
ASO Author Reflections: The Role of Established Prognostic Factors in Long-Term Survival After Resection of Pancreatic Ductal Adenocarcinoma.ASO作者反思：既定预后因素在胰腺导管腺癌切除术后长期生存中的作用
Ann Surg Oncol. 2024 Sep;31(9):6199-6200. doi: 10.1245/s10434-024-15391-w. Epub 2024 May 20.
8
ASO Author Reflections: R Status Is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma.ASO作者反思：R状态是胰腺导管腺癌胰头切除术后复发和生存的相关预后因素。
Ann Surg Oncol. 2021 Aug;28(8):4613-4614. doi: 10.1245/s10434-020-09532-0. Epub 2021 Feb 14.
9
ASO Author Reflections: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: The Challenge of Minimal Residual Disease.ASO作者反思：胰腺导管腺癌根治性切除术后的极早期复发——微小残留病的挑战
Ann Surg Oncol. 2024 Jun;31(6):4115-4116. doi: 10.1245/s10434-024-15175-2. Epub 2024 Mar 12.
10
ASO Author Reflections: Neoadjuvant Chemoradiotherapy for Patients with Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Pancreatectomy Changes Body Composition Influencing Long-term Outcomes.ASO作者反思：接受胰十二指肠切除术的可切除和边界可切除胰腺导管腺癌患者的新辅助放化疗改变身体成分，影响长期预后。
Ann Surg Oncol. 2023 Apr;30(4):2469-2470. doi: 10.1245/s10434-022-13024-8. Epub 2022 Dec 25.

本文引用的文献

1
Aspirin in the Treatment of Cancer: Reductions in Metastatic Spread and in Mortality: A Systematic Review and Meta-Analyses of Published Studies.阿司匹林在癌症治疗中的应用：减少转移扩散和死亡率：已发表研究的系统评价与荟萃分析
PLoS One. 2016 Apr 20;11(4):e0152402. doi: 10.1371/journal.pone.0152402. eCollection 2016.
2
Effect of Metformin Use on Survival in Resectable Pancreatic Cancer: A Single-Institution Experience and Review of the Literature.二甲双胍在可切除胰腺癌患者生存中的作用：单机构经验及文献综述
PLoS One. 2016 Mar 11;11(3):e0151632. doi: 10.1371/journal.pone.0151632. eCollection 2016.
3
The association of statin use after cancer diagnosis with survival in pancreatic cancer patients: a SEER-medicare analysis.
癌症诊断后使用他汀类药物与胰腺癌患者生存率的关联：一项监测、流行病学和最终结果（SEER）医保分析
PLoS One. 2015 Apr 1;10(4):e0121783. doi: 10.1371/journal.pone.0121783. eCollection 2015.
4
Meta-analysis: the use of non-steroidal anti-inflammatory drugs and pancreatic cancer risk for different exposure categories.荟萃分析：不同暴露类别下非甾体抗炎药的使用与胰腺癌风险
Aliment Pharmacol Ther. 2007 Oct 15;26(8):1089-99. doi: 10.1111/j.1365-2036.2007.03495.x.